Results 161 to 170 of about 16,909 (214)

METTL3-m6A-SLC25A11 Axis Promotes Chronic Hypoxia-Induced Cardiomyocyte Ferroptosis. [PDF]

J Am Heart Assoc
Li Y, Xia J, Wei Y, He M, He G, Zhu Y.
europepmc   +1 more source

Advanced glycated end-products modified transferrin mediates oxidative stress and ferroptosis in podocytes via advanced glycation end-product receptor in vitro. [PDF]

Sci Rep
Zhao P, Pan B, Gao J, Lv X, Wang Y, Liu J.   +5 more
europepmc   +1 more source

Deferoxamine for Spontaneous Intracranial Hemorrhage: A Pilot Study on Neurological and Radiological Outcomes. [PDF]

Korean J Neurotrauma
Shirani M, Sohrabiasl M, Meshkini A, Mirzaei F, Hashemi SMM, Jafari F, Salami A, Rafiei E, Iranmehr A.   +8 more
europepmc   +1 more source

Decoding spontaneous intracerebral hemorrhage: mechanistic breakthroughs and disruptive revolution in pharmacological treatment. [PDF]

Exp Mol Med
Chen Y, Wu G, Zhang W, Zou Z, Huang L, Shi H, Wang Q, Chen W, Luo Z, Zhao Z, Wu L, Li Z, Peng J, Chen Y, Zhang JH.   +14 more
europepmc   +1 more source

Aromatic amino acid metabolism shapes autophagy-mediated adaptation to iron deprivation in glioblastoma cells. [PDF]

Biometals
Zhao K, Ludwig-Radtke L, Wang Y, Rusch T, Nimsky C, Taudte RV, Bartsch JW.   +6 more
europepmc   +1 more source

A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori. [PDF]

PLoS One
Ishii M, Mikami K, Tabuchi F, Maruyama N, Miyashita A.   +4 more
europepmc   +1 more source

Evolution of Perihematomal Edema Mean Hounsfield Unit and Its Association with Clinical Outcome in Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial. [PDF]

Neurocrit Care
Polymeris AA, Lioutas VA, Incontri D, Soman S, Selim MH, i-DEF Investigators.   +5 more
europepmc   +1 more source

Redox cycling nitroxide limits cellular iron availability and selectively inhibits iron-sulfur cluster metabolism. [PDF]

Cell Death Discov
Terzi EM, Fujihara KM, Molenaars M, Biancur DE, Possemato R.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Deferoxamine pharmacokinetics

Seminars in Hematology, 2001
Despite the clinical use of deferoxamine for more than a quarter of a century, pharmacokinetic studies are few and have not been performed explicitly in patients with sickle cell disorders. Early studies with Intravenous administration to healthy volunteers and patients with transfusional overload showed that although peak concentrations of ...
openaire   +2 more sources